Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wifling

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Chemical Information and Modeling|August 27, 2019
Universal Activation Index for Class A GPCRsPassainte Ibrahim, David Wifling, Timothy Clark
European Journal of Medicinal Chemistry|November 17, 2020
Water-soluble inhibitors of ABCG2 (BCRP) - A fragment-based and computational approachFrauke Antoni, David Wifling, Günther Bernhardt
Plos One|January 29, 2015
The extracellular loop 2 (ECL2) of the human histamine H4 receptor substantially contributes to ligand binding and constitutive activityDavid Wifling, Günther Bernhardt, Stefan Dove, et al.
Chemistryopen|March 20, 2019
Structure-Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands<sup>†</sup>Steffen Pockes, David Wifling, Armin Buschauer, et al.
RSC Medicinal Chemistry|January 22, 2021
Argininamide-type neuropeptide Y Y<sub>1</sub> receptor antagonists: the nature of <i>N</i> <sup>ω</sup>-carbamoyl substituents determines Y<sub>1</sub>R binding mode and affinityJonas Buschmann, Theresa Seiler, Günther Bernhardt, et al.
Journal of Medicinal Chemistry|July 3, 2020
Oligopeptides as Neuropeptide Y Y<sub>4</sub> Receptor Ligands: Identification of a High-Affinity Tetrapeptide Agonist and a Hexapeptide AntagonistAdam Konieczny, Diana Braun, David Wifling, et al.
ACS Omega|September 18, 2018
Highly Potent, Stable, and Selective Dimeric Hetarylpropylguanidine-Type Histamine HSteffen Pockes, David Wifling, Max Keller, et al.
Journal of Medicinal Chemistry|May 19, 2020
UR-DEBa242: A Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H<sub>3</sub> and H<sub>4</sub> ReceptorsEdith Bartole, Lukas Grätz, Timo Littmann, et al.
Plos One|September 12, 2013
Luciferase reporter gene assay on human, murine and rat histamine H4 receptor orthologs: correlations and discrepancies between distal and proximal readoutsUwe Nordemann, David Wifling, David Schnell, et al.
Journal of Medicinal Chemistry|April 8, 2017
Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M<sub>2</sub> Muscarinic Acetylcholine ReceptorAndrea Pegoli, Xueke She, David Wifling, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Chemical Information and Modeling|August 27, 2019
Universal Activation Index for Class A GPCRsPassainte Ibrahim, David Wifling, Timothy Clark
European Journal of Medicinal Chemistry|November 17, 2020
Water-soluble inhibitors of ABCG2 (BCRP) - A fragment-based and computational approachFrauke Antoni, David Wifling, Günther Bernhardt
Plos One|January 29, 2015
The extracellular loop 2 (ECL2) of the human histamine H4 receptor substantially contributes to ligand binding and constitutive activityDavid Wifling, Günther Bernhardt, Stefan Dove, et al.
Chemistryopen|March 20, 2019
Structure-Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands<sup>†</sup>Steffen Pockes, David Wifling, Armin Buschauer, et al.
RSC Medicinal Chemistry|January 22, 2021
Argininamide-type neuropeptide Y Y<sub>1</sub> receptor antagonists: the nature of <i>N</i> <sup>ω</sup>-carbamoyl substituents determines Y<sub>1</sub>R binding mode and affinityJonas Buschmann, Theresa Seiler, Günther Bernhardt, et al.
Journal of Medicinal Chemistry|July 3, 2020
Oligopeptides as Neuropeptide Y Y<sub>4</sub> Receptor Ligands: Identification of a High-Affinity Tetrapeptide Agonist and a Hexapeptide AntagonistAdam Konieczny, Diana Braun, David Wifling, et al.
ACS Omega|September 18, 2018
Highly Potent, Stable, and Selective Dimeric Hetarylpropylguanidine-Type Histamine HSteffen Pockes, David Wifling, Max Keller, et al.
Journal of Medicinal Chemistry|May 19, 2020
UR-DEBa242: A Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H<sub>3</sub> and H<sub>4</sub> ReceptorsEdith Bartole, Lukas Grätz, Timo Littmann, et al.
Plos One|September 12, 2013
Luciferase reporter gene assay on human, murine and rat histamine H4 receptor orthologs: correlations and discrepancies between distal and proximal readoutsUwe Nordemann, David Wifling, David Schnell, et al.
Journal of Medicinal Chemistry|April 8, 2017
Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M<sub>2</sub> Muscarinic Acetylcholine ReceptorAndrea Pegoli, Xueke She, David Wifling, et al.
Pageof 2